Self-monitoring of blood glucose in individuals with type 2 diabetes not using insulin: Commentary

Canadian Journal of Diabetes

Volumn 34, Issue 1, 2010, Pages 19-23

  Woo, Vincent ^a   Cheng, Alice Y Y ^b   Hanna, Amir ^b   Berard, Lori ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955737374     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-2671(10)41003-5     Document Type: Note

References (34)

1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
2. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545-2559.
3. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560-2572.
4. for the Diabcare-Asia 2003 Study Group. An audit on diabetes management in Asian patients treated by specialists: the Diabcare-Asia 1998 and 2003 studies. Curr Med Res Opin. 2008;24:507-514.
5. Amiel SA, Dixon T, Mann R, et al. Hypoglycaemia in type 2 diabetes. Diabet Med. 2008;25:245-254.
6. Alvarez Guisasola FA, ToféPovedano S, Krishnarajah G, et al. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diab Obes Metab. 2008;10(Suppl 1):25-32.
7. Whitmer RA, Karter AJ, Yaffe K, et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301:1565-1572.
8. Gerich JE. Oral hypoglycemic agents. N Engl J Med. 1989;34: 1231-1245.
9. Shorr RI, Ray WA, Daugherty JR, et al. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med. 1997;157:1681-1686.
10. Holstein A, Plaschke A, Egberts EH. Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide. Diabetes Metab Res Rev. 2001;17:467-473.
11. Matyka K, Evans M, Lomas J, et al. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care. 1997;20:135-141.
12. UK Hypoglycaemia Study Group. Risk of hypoglycemia in type 1 and type 2 diabetes: effects of treatment modalities and their duration. Diabetologia. 2007;50:1140-1147.
13. Akram K, Pedersen-Bjergaard U, Carstensen B, et al. Frequency and risk factors of severe hypoglycemia in insulin-treated type 2 diabetes: a cross-sectional survey. Diabet Med. 2006;23: 750-756.
14. Ginde AA, Espinola JA, Camargo CA Jr. Trends and disparities in U.S. emergency department visits for hypoglycemia, 1993-2005. Diabetes Care. 2008;31:511-513.
15. Karter AJ, Parker MM, Moffet HH, et al. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care. 2006;29:1757-1763.
16. De Berardis G, Pellegrini F, Franciosi M, et al. Longitudinal assessment of quality of life in patients with type 2 diabetes and self-reported erectile dysfunction. Diabetes Care. 2005;28:2637-2643.
17. Blonde L, Ginsberg BH, Horn S, et al. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care. 2002;25:245-246.
18. Gomes T, Juurlink DN, Shah BR, et al. Blood glucose test strips: options to reduce usage. CMAJ. 2009;182:35-38.
19. Harris MI; National Health and Nutrition Examination Survey (NHANES III). Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care. 2001;24:979-982.
20. Evans JM, Newton RW, Ruta DA, et al. Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes database. BMJ. 1999;319:83-86.
21. Karter AJ, Ferrara A, Darbinian JA, et al. Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care. 2000;23:477-483.
22. Davis WA, Bruce DG, Davis TM. Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle Diabetes Study. Diabetologia. 2007;50:510-515.
23. Martin S, Schneider B, Heinemann L, et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia. 2006;49:271-278.
24. Farmer A, Wade A, Goyder E, et al. Impact of self monitoring of blood glucose in the management of patients with noninsulin treated diabetes: open parallel group randomised trial. BMJ. 2007;335:132.
25. Schwedes U, Siebolds M, Mertes G; for the SMBG Study Group. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care. 2002;25:1928-1932.
26. Guerci B, Drouin P, GrangéV, et al; for the ASIA Group. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab. 2003;29:587-594.
27. Welschen LM, Bloemendal E, Nijpels G, et al. Self monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care. 2005;28: 1510-1517.
28. McAndrew L, Schneider SH, Burns E, et al. Does patient blood glucose monitoring improve diabetes control? A systematic review of the literature. Diabetes Educ. 2007;33:991-1011.
29. Poolsup N, Suksomboon N, Rattanasookchit S. Meta-analysis of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients: an update. Diabetes Technol Ther. 2009;11:775-784.
30. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2008;32(suppl 1):S1-S201.
31. American Diabetes Association. Clinical practice recommendations. Executive summary: standards of medical care in diabetes - 2010. Diabetes Care. 2010;33(suppl 1):S4-S10.
32. Colagiuri S, Dickinson S, Girgis S, et al. National Evidence Based Guideline for Blood Glucose Control in Type 2 Diabetes. Canberra, Australia: Diabetes Australia and the National Health and Medical Research Council; 2009. Available at: http://www.nhmrc.gov.au/_files_nhmrc/file/publications/synopses/di19-diabetes-blood-glucose-control.pdf. Accessed April 20, 2010.
33. International Diabetes Federation. Guideline on Self-Monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes. Brussels, Belgium: International Diabetes Federation; 2009. Available at: http://www.idf.org/webdata/docs/SMBG_EN2.pdf. Accessed April 20, 2010.
34. National Institute for Health and Clinical Excellence. National Institute for Health and Clinical Excellence Guideline 66: The Management of Type 2 Diabetes. Available at: http://www.nice.org.uk/nicemedia/pdf/CG66NICEGuideline.pdf. Accessed April 20, 2010.